b
r
c
viral
metagenom
model
protein
structur
manipul
viral
genet
key
approach
laid
foundat
understand
coronaviru
biolog
review
discuss
major
advanc
method
provid
discuss
futur
studi
leverag
strategi
synergist
answer
novel
question
sever
acut
respiratori
syndrom
sar
epidem
first
emerg
southern
china
late
rapidli
spread
worldwid
caus
confirm
case
countri
result
death
world
health
organ
defin
novel
coronaviru
cov
ksiazek
et
al
peiri
et
al
rota
et
al
sarscov
gener
agre
origin
bat
highlight
risk
pose
virus
emerg
zoonot
sourc
guan
et
al
lau
et
al
li
et
al
tang
et
al
tu
et
al
decad
later
middl
east
respiratori
syndrom
cov
merscov
identifi
caus
agent
anoth
ongo
outbreak
five
year
sinc
signific
progress
made
understand
origin
biolog
emerg
potenti
cov
studi
aid
advanc
three
critic
research
area
viral
metagenom
structur
model
studi
revers
genet
review
detail
novel
insight
recent
defin
advanc
approach
discuss
impact
understand
cov
infect
emerg
also
consid
strategi
integr
better
prepar
next
emerg
cov
strain
viral
metagenom
greatli
expand
scope
understand
cov
cov
famili
consist
rel
modest
number
virus
infect
airway
fecalor
tract
known
human
cov
strain
caus
mild
diseas
famili
consid
signific
threat
human
public
health
sar
initi
present
atyp
pneumonia
known
causal
agent
could
determin
peiri
et
al
eventu
novel
cov
isol
infect
patient
sequenc
demonstr
sar
caus
genet
distinct
cov
unknown
origin
peiri
et
al
rota
et
al
earliest
case
sar
occur
food
servic
worker
handl
exot
anim
initi
studi
focus
survey
anim
live
market
presenc
sarscov
progenitor
use
tradit
viral
discoveri
method
includ
seroposit
studi
isol
cultur
visual
virion
use
electron
microscopi
guan
et
al
tu
et
al
viral
discoveri
effort
led
identif
sarscov
strain
himalayan
palm
civet
share
nucleotid
ident
epidem
strain
guan
et
al
later
observ
neither
farm
wild
civet
harbor
sar
antibodi
outsid
live
anim
market
led
investig
zoonot
sourc
sarscov
poon
et
al
tu
et
al
studi
quickli
identifi
sar
progenitor
circul
bat
belong
rhinolophu
genu
commonli
refer
horsesho
bat
full
genom
comparison
determin
progenitor
strain
similar
genom
organ
high
nucleotid
sequenc
ident
sarscov
suggest
epidem
strain
emerg
bat
cov
popul
li
et
al
ren
et
al
tang
et
al
togeth
studi
establish
classic
model
sarscov
emerg
wherebi
civet
initi
infect
sarscov
serv
intermedi
host
lead
gener
adapt
strain
capabl
human
infect
discoveri
progenitor
sarslik
cov
strain
circul
chines
bat
popul
led
global
effort
identifi
defin
phylogenet
relationship
coronavirida
famili
past
year
dozen
anim
popul
survey
fulllength
genom
numer
novel
cov
identifi
greatli
expand
cov
famili
tree
contrast
identif
sarscov
reli
tradit
discoveri
method
expans
cov
famili
tree
larg
occur
viral
metagenom
direct
examin
cov
genet
materi
obtain
environment
sampl
edward
rohwer
simmond
et
al
mani
studi
reli
pcr
base
assay
target
conserv
cov
sequenc
rdrp
gene
advent
inexpens
highthroughput
deep
sequenc
method
like
increasingli
exploit
studi
cov
popul
anthoni
et
al
bries
et
al
cotten
et
al
cotten
et
al
cotten
et
al
donaldson
et
al
current
coronavirida
famili
divid
uniqu
clade
design
alpha
beta
gamma
deltacoronavirus
refer
hereaft
histor
design
group
respect
fig
includ
virus
known
infect
human
bat
mammal
sever
avian
speci
among
cov
design
black
identifi
prior
emerg
sarscov
outbreak
red
immedi
aftermath
green
number
sarscovrel
progenitor
strain
identifi
form
core
new
group
branch
similarli
identif
novel
bat
cov
sequenc
includ
popul
newli
form
group
likewis
discoveri
caus
minor
diseas
human
expand
upon
cov
group
alreadi
exist
togeth
viral
metagenom
studi
wake
sarscov
epidem
provid
first
robust
look
exist
cov
phylogeni
provid
framework
understand
sourc
cov
emerg
expand
phylogeni
born
metagenom
studi
sarscov
allow
rapid
identif
merscov
group
cov
similar
sequenc
novel
human
cov
quickli
distinguish
sarscov
use
reagent
verifi
character
new
strain
agnihothram
et
al
agnihothram
et
al
studi
led
determin
could
bind
merscov
receptor
human
dipeptidyl
peptidas
wang
et
al
sarscov
infect
trace
food
servic
worker
handl
exot
anim
observ
mani
mer
patient
contact
dromedari
camel
led
search
merscov
progenitor
camel
popul
azhar
et
al
reusken
et
al
camel
herd
throughout
middl
east
found
merscov
neutral
antibodi
harbor
cov
nearli
ident
sequenc
merscov
azhar
et
al
haagman
et
al
hemida
et
al
reusken
et
al
examin
histor
serum
sampl
suggest
merscov
present
dromedari
sinc
like
origin
eastern
africa
travel
saudi
arabia
via
camel
trade
muller
et
al
togeth
emerg
merscov
highlight
util
expand
cov
phylogeni
viral
metagenom
studi
sequenc
align
use
muscl
packag
geneiou
tree
construct
use
neighborjoin
method
base
multipl
sequenc
align
also
geneiou
number
parenthes
follow
viru
speci
name
indic
number
sequenc
repres
tree
posit
radial
phylogram
visual
render
public
use
clc
sequenc
viewer
adob
illustr
cc
ba
johnson
et
al
virolog
number
studi
provid
evid
sarscov
origin
bat
viral
metagenom
survey
continu
add
detail
cov
tree
despit
high
sequenc
ident
potenti
sarscov
progenitor
amino
acid
ident
within
domain
spike
protein
li
et
al
ren
et
al
tang
et
al
could
bind
either
civet
human
receptor
angiotensinconvert
enzym
lu
et
al
ren
et
al
howev
recent
survey
east
asia
expand
cov
tree
identifi
sever
new
group
cov
higher
sequenc
ident
sarscov
four
viru
sequenc
cluster
identifi
amino
acid
ident
sarscov
respect
ge
et
al
et
al
yang
et
al
importantli
three
cov
shown
experiment
bind
civet
human
suggest
epidem
strain
sarscov
may
emerg
one
quasispeci
pool
sarslik
cov
popul
ge
et
al
yang
et
al
similarli
distantli
relat
merslik
cov
found
bat
throughout
africa
possibl
spread
merscov
progenitor
viru
es
camel
region
annan
et
al
corman
et
al
ithet
et
al
two
recent
studi
discov
merslik
cov
neocov
share
nucleotid
ident
merscov
anthoni
et
al
corman
et
al
low
sequenc
ident
within
mer
neither
viru
shown
util
human
receptor
suggest
like
emerg
human
even
origin
human
cov
recent
link
bat
sever
cov
sequenc
isol
kenyan
bat
found
close
relat
tao
et
al
togeth
continu
viral
metagenom
survey
provid
critic
resourc
quickli
place
novel
strain
defin
origin
emerg
virus
sinc
emerg
sarscov
viral
metagenom
provid
indispens
tool
studi
cov
examin
cov
current
circul
anim
popul
use
cultur
independ
sequenc
techniqu
allow
field
trace
zoonot
origin
human
cov
progenitor
strain
circul
bat
provid
insight
emerg
viral
metagenom
also
greatli
expand
understand
divers
coronavirida
famili
exemplifi
rapid
classif
merscov
within
exist
group
clade
design
permit
applic
reagent
similar
group
cov
implic
character
treatment
importantli
exist
sar
likeand
mer
likecov
circul
zoonot
popul
indic
continu
threat
emerg
reemerg
cov
use
viral
metagenom
techniqu
surveil
possibl
identifi
help
predict
next
emerg
cov
strain
studi
protein
structur
long
use
understand
biolog
function
develop
therapeut
emerg
virus
includ
influenza
ebola
zika
kang
et
al
saphir
wu
wilson
notabl
cov
research
pioneer
type
studi
context
emerg
viru
outbreak
structur
model
sarscov
spike
protein
provid
insight
transit
new
host
neutral
li
lu
et
al
recent
advanc
structur
biolog
cryoelectron
microscopi
cryoem
permit
recoveri
cov
protein
trimer
conform
kirchdoerf
et
al
pallesen
et
al
wall
et
al
wall
et
al
yuan
et
al
result
effort
improv
understand
cov
biolog
also
open
novel
avenu
therapeut
treatment
follow
origin
sarscov
epidem
structur
studi
protein
provid
insight
viral
emerg
avenu
therapeut
treatment
cov
protein
subdivid
domain
primarili
respons
receptor
bind
domain
respons
fusion
viral
cellular
membran
lu
et
al
crystal
structur
sarscov
receptorbind
domain
rbd
bound
human
indic
presenc
two
subdomain
core
domain
receptorbind
motif
rbm
interact
ntermin
lobe
human
rbm
residu
interact
residu
human
promot
bind
subsequ
studi
demonstr
primari
barrier
host
transit
differ
sequenc
speci
necessit
chang
topolog
charg
within
rbm
li
li
et
al
qu
et
al
wu
et
al
importantli
ineffici
bind
bat
mous
epidem
sarscov
strain
suggest
mutat
requir
emerg
frieman
et
al
hou
et
al
li
robert
et
al
aid
solv
sarscov
structur
epitop
map
previous
known
sarscov
monoclon
neutral
antibodi
mab
reveal
bound
primarili
rbd
like
disrupt
interact
cao
et
al
et
al
et
al
lu
et
al
concord
vaccin
experi
sarscov
rbd
induc
neutral
antibodi
protect
viral
challeng
du
et
al
et
al
et
al
zakhartchouk
et
al
addit
mab
target
rbd
also
develop
prophylaxi
howev
mab
suscept
escap
mutat
lack
neutral
capac
zoonot
sarscov
strain
thu
limit
valu
rockx
et
al
sui
et
al
coupl
identif
addit
sar
likecov
circul
bat
popul
li
et
al
ren
et
al
tang
et
al
initi
therapeut
develop
target
sarscov
rbd
unlik
protect
newli
emerg
infect
howev
structur
studi
provid
import
insight
inform
studi
cov
emerg
therapeut
treatment
futur
emerg
strain
case
viral
metagenom
structur
studi
examin
sarscov
provid
blueprint
investig
merscov
merscov
rbd
rapidli
identifi
crystal
structur
solv
lu
et
al
wang
et
al
merscov
rbd
also
divid
two
subdomain
rbm
bind
merscov
receptor
core
domain
remark
structur
similar
sarscov
core
domain
eighteen
amino
acid
within
rbm
interact
residu
promot
bind
lu
et
al
wang
et
al
differ
host
sequenc
barrier
rel
conserv
among
mammal
barlan
et
al
falzarano
et
al
et
al
raj
et
al
van
doremalen
et
al
common
small
anim
model
notabl
except
mice
rat
hamster
ferret
encod
protein
support
infect
constitut
signific
barrier
merscov
research
barlan
et
al
coleman
et
al
de
wit
et
al
van
doremalen
et
al
like
sarscov
merscov
rbd
also
strong
immunogen
sever
vaccin
studi
demonstr
potenti
induc
neutral
antibodi
du
et
al
du
et
al
mou
et
al
togeth
observ
illustr
structur
predict
util
develop
vaccin
neutral
antibodi
recent
advanc
structur
studi
produc
wealth
new
cov
structur
kirchdoerf
et
al
pallesen
et
al
wall
et
al
wall
et
al
yuan
et
al
previou
effort
made
explor
cov
protein
studi
elucid
portion
includ
postfus
core
rbd
bound
receptor
cryoem
studi
sarscov
virion
provid
insight
glycoprotein
lack
highresolut
cov
trimer
structur
limit
progress
understand
entri
infect
beniac
et
al
neuman
et
al
sever
group
recent
overcam
barrier
fuse
trimer
motif
cov
result
chimer
protein
increas
stabil
permit
first
character
cov
trimer
form
initi
studi
provid
novel
insight
proteolyt
cleavag
viral
fusionentri
conserv
viral
entri
protein
subsequ
studi
spur
wealth
new
data
analysi
solv
cov
trimer
provid
model
upon
base
new
hypothes
analys
initi
sarscov
trimer
structur
indic
posit
sarscov
rbd
within
trimer
may
dynam
rbd
shuffl
expos
stand
state
lie
conform
rbd
buri
ntermin
domain
within
trimer
yuan
et
al
fig
receptor
bind
predict
occur
stand
posit
neutral
antibodi
bind
ntermin
domain
ntd
prevent
conform
switch
may
prove
uniqu
effect
howev
lack
conserv
across
ntd
group
virus
suggest
domain
may
poor
target
fig
contrast
structur
trimer
suggest
sarscov
fusion
peptid
fp
heptad
repeat
region
expos
surfac
trimer
indic
opportun
identifi
neutral
epitop
highli
conserv
region
protein
yuan
et
al
merscov
trimer
also
solv
recent
two
separ
group
like
sarscov
merscov
rbd
also
altern
stand
lie
state
expos
residu
fp
domain
pallesen
et
al
yuan
et
al
importantli
neutral
antibodi
target
region
thoroughli
character
potenti
prophylaxi
agent
pallesen
et
al
addit
studi
examin
trimer
suggest
cov
may
util
glycosyl
prevent
recognit
immunogen
epitop
host
wall
et
al
similar
glycosyl
site
found
sar
merscov
trimer
structur
studi
highlight
area
protein
antibodi
bind
may
inhibit
glycan
shield
yuan
et
al
togeth
structur
data
provid
critic
insight
develop
therapeut
current
potenti
emerg
cov
overal
structur
studi
examin
cov
glycoprotein
provid
invalu
insight
protein
function
therapeut
design
structur
sarsand
merscov
rbd
defin
key
correl
impact
host
tropism
immunogen
featur
vaccin
therapeut
studi
move
forward
solut
trimer
form
cov
protein
creat
opportun
better
understand
model
viral
entri
fusion
importantli
observ
topolog
glycosyl
exploit
develop
univers
therapeut
vaccin
togeth
applic
find
structur
studi
potenti
help
identifi
mitig
potenti
prevent
next
cov
outbreak
use
revers
genet
system
rgss
produc
infecti
particl
manipul
genet
composit
viru
indispens
tool
virolog
perez
cov
sever
system
develop
et
al
use
assess
cov
protein
function
design
therapeut
evalu
emerg
potenti
novel
cov
togeth
rg
platform
key
character
understand
cov
infect
context
recent
outbreak
mani
year
sever
barrier
includ
cov
larg
size
kb
exist
toxic
element
within
genom
promot
genet
instabl
limit
develop
cov
rgss
sever
robust
system
exist
et
al
laboratori
primarili
util
subclon
strategi
origin
develop
transmiss
gastroenter
viru
tgev
subsequ
deploy
cov
includ
sarscov
merscov
becker
et
al
scobey
et
al
yount
et
al
yount
et
al
yount
et
al
briefli
fulllength
cov
genom
divid
cdna
clone
separ
plasmid
class
iig
ii
restrict
site
ad
end
fragment
direct
assembl
fulllength
cdna
cov
genom
vitro
ligat
cov
genom
subsequ
transcrib
fulllength
rna
electropor
cell
produc
viabl
virus
et
al
importantli
fragment
strateg
divid
within
toxic
unstabl
element
break
sequenc
achiev
stabl
propag
subclon
use
smaller
plasmid
propag
target
mutagenesi
also
limit
accumul
undesir
mutat
bacteri
expans
maintain
fidel
sourc
cov
sequenc
togeth
rgss
provid
critic
tool
need
understand
cov
infect
pathogenesi
develop
rgss
mutat
could
easili
made
context
emerg
cov
util
tradit
clone
method
instanc
report
strain
sarscov
merscov
quickli
gener
replac
accessori
orf
report
gene
includ
gfp
rfp
luciferas
scobey
et
al
sim
et
al
yount
et
al
similarli
rgss
key
creation
mouseadapt
cov
follow
vivo
passag
revers
genet
use
reintroduc
adapt
mutat
sarscov
merscov
clone
studi
preserv
uniform
viru
popul
permit
evalu
role
individu
mutat
mous
adapt
cockrel
et
al
day
et
al
frieman
et
al
robert
et
al
revers
genet
also
use
analysi
viral
protein
function
identifi
key
role
viral
antagon
interferon
ifn
respons
inflamm
host
process
snijder
et
al
exampl
ablat
nonstructur
protein
function
replac
key
residu
fig
coronaviru
trimer
structur
provid
new
insight
overal
structur
sarscov
spike
ectodomain
trimer
previous
describ
yuan
et
al
subdivid
ntermin
domain
ntd
orang
receptorbind
domain
rbd
red
ctermin
cleavag
magenta
entir
domain
gray
b
c
two
previous
predict
confirm
state
sar
rbd
region
b
lie
conform
c
stand
conform
spike
protein
sequenc
indic
virus
align
accord
bound
ntd
rbd
sequenc
ident
extract
align
heatmap
sequenc
ident
use
sarscovurbani
refer
sequenc
construct
use
evolview
wwwevolgeniusinfoevolview
heatmap
render
edit
adob
illustr
cc
ba
johnson
et
al
virolog
activ
site
sensit
murin
hepat
viru
mhv
sarscov
type
ifn
respons
attenu
viral
replic
vivo
portend
mutant
potenti
liveattenu
vaccin
platform
menacheri
et
al
et
al
similarli
rgss
use
develop
character
two
liveattenu
vaccin
strategi
via
delet
sarscov
e
inactiv
exonucleas
exon
activ
encod
within
dediego
et
al
fett
et
al
graham
et
al
netland
et
al
togeth
rgss
key
character
cov
infect
defin
viral
protein
function
context
infect
rgss
also
util
analyz
emerg
pathogen
potenti
zoonot
cov
plastic
afford
subclon
system
sequenc
deriv
zoonot
cov
could
evalu
context
viabl
cov
genom
exampl
humancivet
sarscov
chimera
use
demonstr
gene
civet
strain
effici
mediat
viral
replic
cell
express
human
even
within
human
strain
backbon
suggest
mutat
critic
human
emerg
sarscov
addit
signific
barrier
studi
zoonot
cov
includ
difficulti
find
viabl
cultur
system
either
due
receptor
compat
possibl
issu
overal
viral
genom
use
revers
genet
substitut
minim
portion
use
overcom
receptorbind
issu
de
novo
synthes
genom
made
viabl
substitut
portion
sarscov
gene
fig
assembl
chimer
virus
could
infect
replic
effici
vitro
vivo
demonstr
receptor
bind
primari
barrier
infect
human
cell
agnihothram
et
al
becker
et
al
insert
sarscov
rbd
suffici
confer
replic
compet
entir
sarscov
ectodomain
requir
suggest
multipl
domain
protein
may
work
concert
across
cov
group
agnihothram
et
al
complementari
strategi
use
test
capac
cov
gene
mediat
infect
independ
backbon
fig
recent
util
gene
zoonot
cov
insert
replicationcompet
backbon
mous
adapt
sarscov
chimera
could
replic
vitro
vivo
suggest
virus
pois
human
emerg
menacheri
et
al
initi
studi
justifi
examin
character
fulllength
indic
mutat
viral
backbon
also
requir
emerg
pathogenesi
togeth
two
strategi
leverag
revers
genet
creat
chimer
coronavirus
bypass
limit
speci
specif
cultur
system
analyz
emerg
potenti
zoonot
cov
demonstr
rgss
indispens
tool
character
human
zoonot
cov
futur
studi
continu
exploit
util
revers
genet
investig
viral
protein
function
identifi
cov
therapeut
candid
includ
liveattenu
vaccin
candid
base
viral
protein
inactiv
delet
addit
practic
creat
chimer
virus
consist
viabl
portion
establish
cov
conjunct
zoonot
sequenc
greatli
enhanc
util
metagenom
studi
construct
chimera
could
also
prove
use
vaccin
therapeut
develop
candid
efficaci
zoonot
strain
may
predict
util
futur
emerg
virus
howev
revers
genet
studi
involv
creation
chimera
rais
biosafeti
concern
particularli
light
recent
paus
gain
function
studi
associ
influenza
coronavirus
risk
research
natur
taken
lightli
weiss
et
al
import
take
consider
experi
describ
provid
invalu
inform
regard
zoonosi
racaniello
manipul
viral
pathogen
use
revers
genet
system
proven
strategi
character
pathogen
develop
therapeut
debat
futur
role
biomed
research
discuss
evid
base
fashion
casadeval
imperial
futur
studi
need
design
oversight
discuss
scientif
commun
seek
strike
balanc
util
inform
gain
potenti
risk
involv
sinc
emerg
sarscov
metagenom
structur
revers
genet
studi
critic
research
approach
studi
cov
investig
util
viral
metagenom
defin
evolutionari
histori
mani
human
cov
strain
instrument
identifi
numer
zoonot
cov
circul
anim
popul
research
built
structur
model
protein
provid
molecular
explan
host
tropism
identifi
epitop
candid
therapeut
develop
creation
revers
genet
system
member
field
critic
manipul
viral
sequenc
enhanc
understand
cov
protein
function
host
adapt
develop
liveattenu
vaccin
platform
togeth
studi
util
strategi
inform
current
understand
cov
emerg
pathogenesi
treatment
strategi
use
individu
futur
work
take
advantag
complementari
natur
instanc
recent
find
merscov
indic
exploit
sialic
acid
act
secondari
receptor
ntermin
domain
ntd
structur
conserv
li
et
al
diverg
sequenc
among
cov
fig
li
et
al
wall
et
al
wall
et
al
yuan
et
al
revers
genet
use
creat
mutant
chimera
determin
effect
sialic
acid
bind
host
tropism
determin
function
ntd
conserv
across
similar
zoonot
cov
strain
similarli
creat
chimer
virus
revers
genet
alreadi
proven
vital
studi
zoonot
virus
agnihothram
et
al
becker
et
al
menacheri
et
al
menacheri
et
al
sheahan
et
al
effort
explor
chang
structur
protein
zoonot
strain
rel
establish
strain
may
reveal
structur
requir
necessari
emerg
revers
genet
structur
studi
identifi
conserv
featur
associ
emerg
pathogenesi
help
identifi
cov
identifi
anim
popul
like
pose
fig
dual
approach
leverag
revers
genet
util
coronaviru
molecular
clone
two
strategi
employ
explor
emerg
pathogen
potenti
sequenc
deriv
zoonot
popul
replac
wildtyp
spike
protein
strategi
explor
capac
spike
protein
within
context
viral
backbon
known
capabl
replic
studi
provid
insight
potenti
spike
protein
mediat
infect
human
cell
caus
vivo
diseas
aid
examin
broad
efficaci
therapeut
direct
cov
spike
protein
b
util
portion
whole
spike
protein
replicationcompet
cov
approach
examin
capac
viral
backbon
mediat
infect
pathogenesi
studi
provid
insight
whether
backbon
capac
infect
caus
diseas
pair
receptor
bindingentri
approach
also
evalu
efficaci
therapeut
target
portion
cov
genom
spike
approach
use
examin
bat
virus
current
circul
anim
popul
around
world
ba
johnson
et
al
virolog
public
health
risk
merit
studi
addit
insight
strategi
appli
exist
experiment
system
exampl
variat
host
respons
infect
current
major
area
research
aylor
et
al
menacheri
baric
model
host
genet
divers
collabor
cross
cc
mous
panel
identifi
genet
loci
modul
sarscov
diseas
outcom
xiong
et
al
appli
insight
viral
metagenom
structur
revers
genet
offer
opportun
util
cc
identifi
host
gene
contribut
emerg
zoonot
cov
similarli
hostpathogen
interact
may
influenc
modul
viral
sequenc
structur
revers
genet
system
util
confirm
hypothes
togeth
synergist
use
metagenom
structur
biolog
revers
genet
system
signific
potenti
identifi
molecular
determin
cov
infect
pathogenesi
integr
three
strategi
help
character
preemerg
cov
popul
allow
field
make
predict
zoonot
cov
like
emerg
prepar
futur
outbreak
facilit
develop
therapeut
strategi
cov
infect
